EAM Investors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-72,995
| Closed | -$8.34M | – | 329 |
|
|
2024
Q3 | $8.34M | Buy |
72,995
+36,473
| +100% | +$4.17M | 1.25% | 2 |
|
|
2024
Q2 | $2.76M | Sell |
36,522
-7,210
| -16% | -$544K | 0.45% | 120 |
|
|
2024
Q1 | $2.99M | Buy |
+43,732
| New | +$2.99M | 0.47% | 119 |
|
|
2023
Q4 | – | Sell |
-17,289
| Closed | -$881K | – | 346 |
|
|
2023
Q3 | $881K | Sell |
17,289
-43,265
| -71% | -$2.21M | 0.17% | 257 |
|
|
2023
Q2 | $3.02M | Buy |
60,554
+10,691
| +21% | +$534K | 0.56% | 51 |
|
|
2023
Q1 | $1.87M | Sell |
49,863
-14,962
| -23% | -$561K | 0.37% | 126 |
|
|
2022
Q4 | $3.11M | Buy |
+64,825
| New | +$3.11M | 0.64% | 33 |
|